CVS analysis as of 06/1/2023

• CVS Health Corporation is a healthcare company that provides pharmacy benefits management, retail/LTC, and health care benefits.
• The company was formed in 1996 through the merger of CVS Corporation and Caremark Rx.
• CVS Health Corporation is headquartered in Woonsocket, Rhode Island.
• The company has over 219,000 employees and operates over 10,000 retail pharmacies in the United States.
• In 2022, CVS Health Corporation generated $329.9 billion in revenue and $19.2 billion in net income.
• The company's stock is currently trading at $69.68 per share.
• Analysts have a "buy" rating on the stock with a target price of $98.18 per share.

CVS Health Corporation is a well-established healthcare company with a strong track record of growth. The company is a leader in the pharmacy benefits management industry and has a large network of retail pharmacies. CVS Health Corporation is also expanding into other healthcare areas, such as MinuteClinic and health insurance.

The company faces some challenges, such as increasing competition from other healthcare companies and the rise of the generic drug market. However, CVS Health Corporation is well-positioned to continue to grow in the future.

Here are some additional details about CVS Health Corporation:

• The company's pharmacy benefits management (PBM) segment offers a variety of services, including drug benefit design, administration, and pharmacy network management.
• The company's retail/LTC segment operates retail pharmacies, MinuteClinic walk-in medical clinics, and long-term care pharmacies.
• The company's health care benefits segment offers health insurance, Medicare Advantage, and Medicaid plans.
• CVS Health Corporation is committed to improving the health and well-being of its customers and communities. The company has a number of programs and initiatives in place to support this goal, such as its MinuteClinic walk-in medical clinics and its Healthy Living program.

I hope this summary is helpful. Please let me know if you have any other questions.

Here are some key financial measures of CVS Health Corporation:

1. Earnings Per Share (EPS): The EPS for CVS is $3.01, which indicates the company's profitability per outstanding share.

2. Trailing Price to Earnings Ratio: The trailing P/E ratio for CVS is 23.1495. This ratio measures the price investors are willing to pay for each dollar of earnings generated by the company.

3. Price to Book Ratio: The price to book ratio is 1.2485, which compares the company's market price per share to its book value per share. It indicates whether the stock is overvalued or undervalued.

4. Dividend Yield (%): CVS has a dividend yield of 3.6%. This percentage represents the annual dividend payment as a percentage of the stock's current market price.

5. Return on Equity (ROE): The ROE for CVS is 5.424%. This measure shows the profitability of the company relative to the shareholders' equity invested.

6. Debt to Equity Ratio: CVS has a debt to equity ratio of 106.843, which indicates the proportion of debt relative to shareholders' equity. It measures the company's financial leverage and risk.

7. Free Cash Flow: CVS generated free cash flow of $16,966.8 million. Free cash flow represents the cash generated by the company's operations after accounting for capital expenditures.

8. Market Capitalization: The market capitalization of CVS is $89,331.9 million. It represents the total market value of the company's outstanding shares.

9. Revenue Growth (%): CVS has achieved revenue growth of 10.8% over the specified period. This figure indicates the percentage increase in the company's revenue over time.

10. Operating Margin (%): The operating margin for CVS is 4.539%. This margin reflects the company's profitability by measuring the percentage of revenue that remains as operating income after deducting operating expenses.

11. Forward Price to Earnings Ratio: The forward P/E ratio for CVS is 7.82043. It is a projection of the P/E ratio based on future expected earnings.

These financial measures provide insights into CVS Health Corporation's earnings, valuation, dividend policy, profitability, leverage, and growth.

Here are some key financial measures of CVS Health Corporation:

1. Earnings Per Share (EPS): The EPS for CVS is $3.01, which indicates the company's profitability per outstanding share.

2. Trailing Price to Earnings Ratio: The trailing P/E ratio for CVS is 23.1495. This ratio measures the price investors are willing to pay for each dollar of earnings generated by the company.

3. Price to Book Ratio: The price to book ratio is 1.2485, which compares the company's market price per share to its book value per share. It indicates whether the stock is overvalued or undervalued.

4. Dividend Yield (%): CVS has a dividend yield of 3.6%. This percentage represents the annual dividend payment as a percentage of the stock's current market price.

5. Return on Equity (ROE): The ROE for CVS is 5.424%. This measure shows the profitability of the company relative to the shareholders' equity invested.

6. Debt to Equity Ratio: CVS has a debt to equity ratio of 106.843, which indicates the proportion of debt relative to shareholders' equity. It measures the company's financial leverage and risk.

7. Free Cash Flow: CVS generated free cash flow of $16,966.8 million. Free cash flow represents the cash generated by the company's operations after accounting for capital expenditures.

8. Market Capitalization: The market capitalization of CVS is $89,331.9 million. It represents the total market value of the company's outstanding shares.

9. Revenue Growth (%): CVS has achieved revenue growth of 10.8% over the specified period. This figure indicates the percentage increase in the company's revenue over time.

10. Operating Margin (%): The operating margin for CVS is 4.539%. This margin reflects the company's profitability by measuring the percentage of revenue that remains as operating income after deducting operating expenses.

11. Forward Price to Earnings Ratio: The forward P/E ratio for CVS is 7.82043. It is a projection of the P/E ratio based on future expected earnings.

These financial measures provide insights into CVS Health Corporation's earnings, valuation, dividend policy, profitability, leverage, and growth.

           Financial Measure  Percentile Stock
0                           EPS         22.222222
1                     P/E Ratio         52.083333
2                     P/B Ratio         15.384615
3            Dividend Yield (%)         69.047619
4              Return On Equity          9.890110
5                Debt to Equity         50.000000
6   Free cash Flow (in million)         86.363636
7       Market Cap (in million)         25.000000
8                Revenue Growth         76.530612
9              Operating Margin          8.080808
10                        Total        414.602957

The following table presents the percentiles of CVS Health Corporation's financial measures compared to the S&P 100 stocks:

These percentiles indicate how CVS Health Corporation's financial measures compare to the S&P 100 stocks on a relative basis. For example, CVS's EPS is at the 22.22nd percentile, suggesting that its earnings per share performance is better than approximately 22.22% of the companies in the S&P 100 index. Similarly, the P/E ratio of CVS is at the 52.08th percentile, indicating that its valuation in terms of price-to-earnings ratio is higher than approximately 52.08% of the S&P 100 stocks.

It is important to note that the percentiles provide a comparative measure within the S&P 100 index, giving an indication of CVS's position relative to its peers in terms of these financial measures.